Phillip

Silence in the face of evil is itself evil. God will not hold us guiltless.Not to speak is to speak. Not to act is to act.-Dietrich Bonhoeffer

[DNI Tulsi Gabbard @DNIGabbard]

Today, on my final day as Director of National Intelligence, I’m releasing never-before-seen communications and documents exposing how Dr. Fauci provided millions in US taxpayer dollars to fund dangerous gain-of-function research at the Wuhan lab, worked with politicized elements within the Intelligence Community to suppress the truth about his actions and hide the virus’ lab-leak origins, and lied to Congress while under oath in 2024. It’s time you know the truth.

https://t.co/3YJSstB7d4

[mcgill_medicines @mcgillmedicines]

🚨New study of 197 cancer patients treated with Ivermectin (25 mg) + Mebendazole (250 mg):

After 6 months:
• 84.4% had clinical benefit
• 48.4% had tumor reduction or no detectable disease • 86.9% completed treatment with mild side effects Dr. Peter McCullough explains. Details

[Hunter Williams @HunterEsoteric]

Most guys give up on peptide research within 2 weeks.

There's no central source. Reddit threads contradict each other. Half the dosing info on blogs is straight wrong.

I put everything you actually need to know about 12 peptides into one PDF.

Free download below.

[Hunter Williams @HunterEsoteric]

5 peptides every guy over 30 should know about:

BPC-157
TB-500
Tesamorelin
Ipamorelin
AOD 9604

I broke down what each one does and how guys are actually using them. Free cheatsheet, link below.

[Nicolas Hulscher, MPH @NicHulscher]

BREAKING: Largest Human Cancer Study of Ivermectin + Mebendazole Is Now PEER-REVIEWED and PUBLISHED in a MAJOR Cancer Journal

84.4% of cancer patients taking ivermectin + mebendazole for 6 months declared either CANCER DISAPPEARANCE, TUMOR REGRESSION, or CANCER STABILIZATION.

Our study, “Real-world Clinical Outcomes of Ivermectin and Mebendazole in Cancer Patients: Results from a Prospective Observational Cohort,” is now peer-reviewed and published in Anticancer Research—a major international oncology journal of the International Institute of Anticancer Research (IIAR), established in 1995.

The results represent one of the most compelling clinical signals ever documented for repurposed anti-parasitic therapies in oncology.

A diverse population of cancer patients (n=197) was prescribed compounded ivermectin–mebendazole through a U.S. telemedicine platform, with each capsule containing 25 mg ivermectin and 250 mg mebendazole.

Participants were followed for approximately six months using standardized digital surveys assessing cancer outcomes, medication adherence, and tolerability.

At approximately six months post-treatment initiation, we observed an 84.4% Clinical Benefit Ratio (CBR)—meaning more than four out of five patients reported either:
No evidence of disease (32.8%)
Tumor regression (15.6%)
or Cancer stabilization (36.1%)

Importantly, adherence was remarkably high, with 86.9% completing the initial prescription and 66.4% remaining on therapy at six months.

Side effects were predominantly mild and manageable, reported in 25.4% of patients (primarily gastrointestinal), with 93.6% of those experiencing side effects continuing treatment after minor dosing adjustments.

This groundbreaking peer-reviewed publication was made possible through a unique collaboration between The Wellness Company, the McCullough Foundation, and the Chairman of the President’s Cancer Panel—uniting real-world clinical data, frontline medical experience, and epidemiologic expertise to evaluate inexpensive, repurposed therapies with major translational potential.

With these extraordinarily promising results, double-blind, placebo-controlled clinical trials are now required.

In the meantime, many cancer patients are exercising their right to try.

@twc_health @McCulloughFund @IIAR_Journals @P_McCulloughMD @DrHarveyRisch @DrKellyVictory @jathorpmfm @drdrew @PeterGillooly @FosterCoulson

[Valerie Anne Smith @ValerieAnne1970]

IVERMECTIN: FULL DOSAGE SCHEDULE FOR CANCER & PREVENTION

1000s of people use Dr. William Makis MD’s IVERMECTIN dosing chart. Here’s a clear, categorized breakdown based on body weight (mg/kg per day).

LOW DOSE: ≤ 0.5 mg/kg/day
**Best for:**
- Cancers in remission
- Strong family history or genetic predisposition
- Prophylaxis (preventive)
**Side effects:** No long-term side effects reported.
**Example:** Dr. Tess Lawrie reported a Stage 3 ovarian cancer case treated with chemo + 12 mg ivermectin daily. Tumor marker CA125 dropped from 288 to 22 after 2 months and the tumor vanished.

MEDIUM DOSE: 1.0 mg/kg/day
**Best for:** Starting dose for **most cancers** (lung, pancreatic, renal cell, gastric, etc.).
**Side effects:** No long-term side effects reported.
**Example:** Dr. Shankara Chetty’s 70-year-old prostate cancer patient (PSA 89) took 45 mg/day (plus lactoferrin). After two months PSA fell to 10.9.

HIGH DOSE: 2.0 mg/kg/day
**Best for:** Very aggressive cancers (leukemia, pancreatic, brain cancers).
**Side effects:** No long-term side effects reported.
**Example:** Dr. Allan Landrito’s Stage 4 gallbladder cancer patient took 2 mg/kg daily for 14 months — cancer disappeared.

VERY HIGH DOSE: ≥ 2.5 mg/kg/day
**Best for:** Extensive metastatic disease, extremely poor prognosis, or certain brain cancers.
**Side effects:** Possible short-term & transient visual effects (usually resolve in a few days).
**Example:** Dr. Shankara Chetty treated a patient with 2.5 mg/kg/day — no side effects reported.

**Quick conversion example (for a 60 kg / 132 lb person):**
- Low: ≤30 mg/day
- Medium: 60 mg/day (≈5×12 mg tablets or 1 teaspoon liquid)
- High: 120 mg/day
- Very High: ≥150 mg/day

Many anecdotal reports exist of long-term daily use (months to over a year) with no serious toxicity, but individual responses vary.

Always work with a knowledgeable clinician, especially if you have pre-existing conditions (e.g., vision issues or glaucoma). This is for educational purposes only.

Share to spread awareness — information is power. 💊

[Franklin Graham @Franklin_Graham]

“For I am persuaded, that neither death, nor life, nor angels, nor principalities, nor powers, nor things present, nor things to come, nor height, nor depth, nor any other creature, shall be able to separate us from the love of God, which is in Christ Jesus our Lord.” (Romans 8:38-39)

[Thomas Sowell Quotes @ThomasSowell]

"Just as any moron can destroy a priceless Ming vase, so the shallow and ill-educated people who run our schools can undermine and destroy from within a great civilization that took centuries of dedicated effort to create and maintain."

— Thomas Sowell

[Mike Lee @BasedMikeLee]

Please share if you support @DOGE

[Jack Posobiec @JackPosobiec]

GM Christ is King

[Dr. Lynn Fynn-derella (ret) @Fynnderella1]

Great interview. Oddly, @SpeakerJohnson had him removed from the rules committee. I will say @RepThomasMassie is 100% #AmericaFirst. He is the best of the best. The powers that be can be wrong.
@KLVeritas

[Eric Metaxas @ericmetaxas]

Let's do this! MAKE AMERICA FUN AGAIN!

[Ron DeSantis @RonDeSantis]

Retweet if you’d like to see this man — Dr. Joseph Ladapo — serve as the Secretary of HHS in the new Trump administration. cc: ⁦@FLSurgeonGen⁩

[Sara Gonzales @SaraGonzalesTX]

https://t.co/05HGzWgUCY

[nascarcasm @nascarcasm]

Every October I challenge @JRMotorsports to turn the corn numbers into candy corn numbers - nature's greatest candy. And I'm doing it again this year. I am relentless. #NASCAR

[“Sudden And Unexpected” @toobaffled]

A recent pre-print study by a team of Japanese researchers has ignited a heated debate within the medical community, revealing serious risks associated with blood transfusions taken from individuals who have received COVID-19 vaccinations. The study highlights six key areas where COVID jabs destroy the continuity and biochemistry of human blood. The study has called into question the safety of using such blood in medical procedures.

According to the researchers, the COVID-19 vaccines — which have failed to stimulate a meaningful immune response to the SARS-CoV-2 virus — have unintended consequences that affect blood integrity. The team’s findings suggest that the vaccines can induce harmful changes in blood, which could pose risks not only to recipients of blood transfusions but also to those receiving organ transplants from vaccinated donors.

https://t.co/lVIrAssQQV

[William Makis @MakisMedicine]

NEW ARTICLE: TOPICAL IVERMECTIN - Atopic Dermatitis, Rosacea, perioral dermatitis, seborrheic dermatitis, acne vulgaris - Ivermectin has powerful anti-inflammatory properties when applied topically!

There are several studies now showing efficacy of topical Ivermectin cream or paste in treating a whole range of inflammatory skin conditions (non-parasitic):

2017 Ventre et al:
Conclusion: “We investigated a murine model of atopic dermatitis...IVM is endowed with topical anti-inflammatory properties that could have important applications for the treatment of T-cell-mediated skin inflammatory diseases.”

2018 Ebbelaar et al:
"Ivermectin is an effective treatment option for papulopustular Rosacea and seems to be more effective than metronidazole (NNT = 10.5) at 12 weeks of treatment."

2017 Noguera-Morel et al: A series of 15 cases:
"Treatment of papulopustular rosacea (PPR) and periorificial dermatitis (POD) can be challenging in children."

"The overall response to topical or oral ivermectin was excellent: 14 of 15 (93%) patients achieved complete or almost complete clearance of lesions"

2019 Schaller et al:
“Adding doxycycline 40-mg modified release (DMR) capsules, to daily ivermectin 1% cream can produce faster responses, improve response rates, and increase patient satisfaction in cases of severe rosacea compared with 1% ivermectin alone.”

2019 - Baranska-Rybak et al:
"The aim of our study was to assess the benefit and tolerability of topical ivermectin therapy in mild and moderate perioral dermatitis, seborrheic dermatitis SD and acne vulgaris AV."

"Onset of treatment effect can be seen as early as 2 weeks after treatment initiation with 1% ivermectin cream in monotherapy."

"We present 20 cases of different facial inflammatory dermatoses - Overall 19 patients reported “very good” and “excellent” improvement"

Both Pfizer and Moderna COVID-19 mRNA Vaccines cause a wide range of autoimmune and inflammatory skin conditions. If you are suffering from such vaccine skin injuries, consider a trial of topical Ivermectin.

"In December 2014, the US Food and Drug Administration approved 1% ivermectin cream for treatment of rosacea in adults while the first European approval was obtained in March 2015."

Much more in this extensive article (don't miss this one!)

Article Link in photo to avoid shadowban, just re-type the URL in the 1st photo at the top, into your browser to access

@JoeRogan
@TuckerCarlson

[Daniel Horowitz @RMConservative]

It's not just about Springfield, not just about Haitians, and not just about eating cats...It's a much broader problem we are missing:

Here are just a few stats on the depth, breadth, and danger of this invasion.

[Jessica Rojas 🇺🇸💪 @VoicesUnheard]

Really important information to be aware of.

"On August 30th, 2024 the FDA approved the new ACAM2000 smallpox vaccine for use against monkey pox.

The warning label of this vaccine says:

"Individuals who are vaccinated with this vaccine should quarantine for 4 weeks after injection. During this quarantine individuals cannot handle babies, be around pregnant women, cannot go swimming or be in hot tubs, cannot use public restrooms, share a bed, clothing, or be in close contact with an unvaccinated individual."

It also says on the warning label that this ACAM2000 smallpox vaccine "may cause the spread of smallpox".
But the worst part. . .at the bottom of this vaccine insert, it states- "Death of unvaccinated individuals who have contact with vaccinated individuals may occur".